156 related articles for article (PubMed ID: 2926081)
1. Analysis of the wheal-and-flare reactions that follow the intradermal injection of histamine and morphine in adults with recurrent, unexplained anaphylaxis and systemic mastocytosis.
Keffer JM; Bressler RB; Wright R; Kaliner MA; Metcalfe DD
J Allergy Clin Immunol; 1989 Mar; 83(3):595-601. PubMed ID: 2926081
[TBL] [Abstract][Full Text] [Related]
2. Failure of sulfites to produce clinical responses in patients with systemic mastocytosis or recurrent anaphylaxis: results of a single-blind study.
Meggs WJ; Atkins FM; Wright R; Fishman M; Kaliner MA; Metcalfe DD
J Allergy Clin Immunol; 1985 Dec; 76(6):840-6. PubMed ID: 3905921
[TBL] [Abstract][Full Text] [Related]
3. Analysis of plasma histamine levels in patients with mast cell disorders.
Friedman BS; Steinberg SC; Meggs WJ; Kaliner MA; Frieri M; Metcalfe DD
Am J Med; 1989 Dec; 87(6):649-54. PubMed ID: 2589400
[TBL] [Abstract][Full Text] [Related]
4. Mastocytosis and insect venom allergy.
Bonadonna P; Zanotti R; Müller U
Curr Opin Allergy Clin Immunol; 2010 Aug; 10(4):347-53. PubMed ID: 20485157
[TBL] [Abstract][Full Text] [Related]
5. Markers of mast cell degranulation.
Hogan AD; Schwartz LB
Methods; 1997 Sep; 13(1):43-52. PubMed ID: 9281467
[TBL] [Abstract][Full Text] [Related]
6. Use of plasma histamine levels to monitor cutaneous mast cell degranulation.
McBride P; Jacobs R; Bradley D; Kaliner M
J Allergy Clin Immunol; 1989 Feb; 83(2 Pt 1):374-80. PubMed ID: 2465333
[TBL] [Abstract][Full Text] [Related]
7. Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients.
Boehm T; Reiter B; Ristl R; Petroczi K; Sperr W; Stimpfl T; Valent P; Jilma B
Allergy; 2019 Mar; 74(3):583-593. PubMed ID: 30418682
[TBL] [Abstract][Full Text] [Related]
8. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
[TBL] [Abstract][Full Text] [Related]
9. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients.
Brockow K; Jofer C; Behrendt H; Ring J
Allergy; 2008 Feb; 63(2):226-32. PubMed ID: 18186813
[TBL] [Abstract][Full Text] [Related]
10. The presence of mast cell clonality in patients with unexplained anaphylaxis.
Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
[TBL] [Abstract][Full Text] [Related]
11. Mastocytosis and the Fig Wasp (Blastophaga psenes).
Armentia A; Pineda F; Fernandez-Cortés S; Moro A; Martin-Armentia B; Mendez P; Porcuna A; Mendez-Alcalde J
Int Arch Allergy Immunol; 2019; 178(3):291-294. PubMed ID: 30625461
[TBL] [Abstract][Full Text] [Related]
12. Wheal and flare responses to opioids in humans.
Levy JH; Brister NW; Shearin A; Ziegler J; Hug CC; Adelson DM; Walker BF
Anesthesiology; 1989 May; 70(5):756-60. PubMed ID: 2470272
[TBL] [Abstract][Full Text] [Related]
13. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.
Schwartz LB; Metcalfe DD; Miller JS; Earl H; Sullivan T
N Engl J Med; 1987 Jun; 316(26):1622-6. PubMed ID: 3295549
[TBL] [Abstract][Full Text] [Related]
14. Hymenoptera Allergy and Mast Cell Activation Syndromes.
Bonadonna P; Bonifacio M; Lombardo C; Zanotti R
Curr Allergy Asthma Rep; 2016 Jan; 16(1):5. PubMed ID: 26714690
[TBL] [Abstract][Full Text] [Related]
15. Wheal-and-flare responses to intradermally injected adenosine 5'-monophosphate, hypertonic saline, and histamine: comparison of atopic and nonatopic subjects.
Djukanovic R; Finnerty JP; Holgate ST
J Allergy Clin Immunol; 1989 Sep; 84(3):373-8. PubMed ID: 2506263
[TBL] [Abstract][Full Text] [Related]
16. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
[TBL] [Abstract][Full Text] [Related]
17. Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis.
Friedman BS; Santiago ML; Berkebile C; Metcalfe DD
J Allergy Clin Immunol; 1993 Oct; 92(4):520-6. PubMed ID: 8104966
[TBL] [Abstract][Full Text] [Related]
18. Antihistaminic efficacy of Ranitidine with & without Dimethendine maleate on histamine-induced cutaneous reactions.
Chauhan CK; Shahani SR
Indian J Med Res; 1992 Apr; 96():128-32. PubMed ID: 1358821
[TBL] [Abstract][Full Text] [Related]
19. [Drug hypersensitivity in patients with presumed histamine intolerance and mast cell activation disease].
Schmid-Grendelmeier P; Schnyder B
Ther Umsch; 2019 Jul; 75(1):38-42. PubMed ID: 31282837
[TBL] [Abstract][Full Text] [Related]
20. Hymenoptera-induced anaphylaxis: is it a mast cell driven hematological disorder?
Brockow K; Akin C
Curr Opin Allergy Clin Immunol; 2017 Oct; 17(5):356-362. PubMed ID: 28796123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
